These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 9109533)

  • 1. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease.
    Lyras L; Cairns NJ; Jenner A; Jenner P; Halliwell B
    J Neurochem; 1997 May; 68(5):2061-9. PubMed ID: 9109533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased nuclear DNA oxidation in the brain in Alzheimer's disease.
    Gabbita SP; Lovell MA; Markesbery WR
    J Neurochem; 1998 Nov; 71(5):2034-40. PubMed ID: 9798928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies.
    Lyras L; Perry RH; Perry EK; Ince PG; Jenner A; Jenner P; Halliwell B
    J Neurochem; 1998 Jul; 71(1):302-12. PubMed ID: 9648879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease.
    Wang J; Xiong S; Xie C; Markesbery WR; Lovell MA
    J Neurochem; 2005 May; 93(4):953-62. PubMed ID: 15857398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence for increased oxidative damage to lipids, proteins, or DNA in Huntington's disease.
    Alam ZI; Halliwell B; Jenner P
    J Neurochem; 2000 Aug; 75(2):840-6. PubMed ID: 10899962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid peroxidation and nitrite plus nitrate levels in brain tissue from patients with Alzheimer's disease.
    DiCiero Miranda M; de Bruin VM; Vale MR; Viana GS
    Gerontology; 2000; 46(4):179-84. PubMed ID: 10859455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide.
    Butterfield DA; Drake J; Pocernich C; Castegna A
    Trends Mol Med; 2001 Dec; 7(12):548-54. PubMed ID: 11733217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of oxidative damage to lipids, nucleic acids and proteins and antioxidant enzymes activities in Alzheimer's disease brain: A meta-analysis in human pathological specimens.
    Zabel M; Nackenoff A; Kirsch WM; Harrison FE; Perry G; Schrag M
    Free Radic Biol Med; 2018 Feb; 115():351-360. PubMed ID: 29253591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment.
    Wang J; Markesbery WR; Lovell MA
    J Neurochem; 2006 Feb; 96(3):825-32. PubMed ID: 16405502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease.
    Lovell MA; Markesbery WR
    Nucleic Acids Res; 2007; 35(22):7497-504. PubMed ID: 17947327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein and DNA oxidation in different anatomic regions of rat brain in a mimetic ageing model.
    Yanar K; Aydın S; Cakatay U; Mengi M; Buyukpınarbaşılı N; Atukeren P; Sitar ME; Sönmez A; Uslu E
    Basic Clin Pharmacol Toxicol; 2011 Dec; 109(6):423-33. PubMed ID: 21733122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of DNA excision-repair-cross-complementing proteins p80 and p89 in brain of patients with Down Syndrome and Alzheimer's disease.
    Hermon M; Cairns N; Egly JM; Fery A; Labudova O; Lubec G
    Neurosci Lett; 1998 Jul; 251(1):45-8. PubMed ID: 9714461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA oxidation in Alzheimer's disease.
    Markesbery WR; Lovell MA
    Antioxid Redox Signal; 2006; 8(11-12):2039-45. PubMed ID: 17034348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease.
    Lovell MA; Ehmann WD; Butler SM; Markesbery WR
    Neurology; 1995 Aug; 45(8):1594-601. PubMed ID: 7644059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
    Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
    J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.
    Butterfield DA; Reed TT; Perluigi M; De Marco C; Coccia R; Keller JN; Markesbery WR; Sultana R
    Brain Res; 2007 May; 1148():243-8. PubMed ID: 17395167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment.
    Markesbery WR; Lovell MA
    Arch Neurol; 2007 Jul; 64(7):954-6. PubMed ID: 17620484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain.
    Lovell MA; Soman S; Bradley MA
    Mech Ageing Dev; 2011 Aug; 132(8-9):443-8. PubMed ID: 21878349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease.
    Aksenov MY; Tucker HM; Nair P; Aksenova MV; Butterfield DA; Estus S; Markesbery WR
    J Mol Neurosci; 1998 Oct; 11(2):151-64. PubMed ID: 10096042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment.
    Markesbery WR; Kryscio RJ; Lovell MA; Morrow JD
    Ann Neurol; 2005 Nov; 58(5):730-5. PubMed ID: 16240347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.